Results 21 to 30 of about 5,328 (197)

Auranofin Has Advantages over First-Line Drugs in the Treatment of Severe Streptococcus suis Infections

open access: yesAntibiotics, 2020
Streptococcal toxic shock-like syndrome (STSLS) likely occurs when an individual is infected with the Streptococcus suis (S. suis) epidemic strain and is characterized by a cytokine storm, multiple organ dysfunction syndrome (MODS) and a high incidence ...
Hao Lu   +10 more
doaj   +2 more sources

Gold(I) ion and the phosphine ligand are necessary for the anti-Toxoplasma gondii activity of auranofin [PDF]

open access: yesMicrobiology Spectrum
Auranofin, an FDA-approved drug for rheumatoid arthritis, has emerged as a promising antiparasitic medication in recent years. The gold(I) ion in auranofin is postulated to be responsible for its antiparasitic activity.
C. I. Ma   +11 more
doaj   +2 more sources

Auranofin accelerates spermidine-induced apoptosis via reactive oxygen species generation and suppression of PI3K/Akt signaling pathway in hepatocellular carcinoma

open access: yesFisheries and Aquatic Sciences, 2023
Auranofin is a US Food and Drug Administration (FDA)-approved anti-arthritis medication that functions as a thioredoxin reductase inhibitor. Spermidine, a polyamine present in marine algae, can exert various physiological functions.
Hyun Hwangbo   +7 more
doaj   +1 more source

Anti-Cancer Effects of Auranofin in Human Lung Cancer Cells by Increasing Intracellular ROS Levels and Depleting GSH Levels

open access: yesMolecules, 2022
Auranofin, as a thioredoxin reductase (TrxR) inhibitor, has promising anti-cancer activity in several cancer types. However, little is known about the inhibitory effect of auranofin on lung cancer cell growth.
Xia Ying Cui   +2 more
doaj   +1 more source

Investigating auranofin for the treatment of infected diabetic pressure ulcers in mice and dermal toxicity in pigs

open access: yesScientific Reports, 2021
Bacterial infection of pressure ulcers (PUs) are a notable source of hospitalization for individuals with diabetes. This study evaluated the safety profile and efficacy of auranofin to treat diabetic PUs infected with methicillin-resistant Staphylococcus
Haroon Mohammad   +4 more
doaj   +1 more source

Gold Nanoclusters as Nano-Antibiotic Auranofin Analogues

open access: yes, 2021
Auranofin, a gold(I)-complex with tetraacetylated thioglucose and triethylphosphine ligands, is an FDA-approved drug used as an anti-inflammatory aid in the treatment of rheumatoid arthritis.
Mingdi, Yan   +4 more
core   +1 more source

Synergistic Activity of Colistin Combined With Auranofin Against Colistin-Resistant Gram-Negative Bacteria

open access: yesFrontiers in Microbiology, 2021
Colistin-resistant (Col-R) bacteria are steadily increasing, and are extremely difficult to treat. New drugs or therapies are urgently needed to treat infections caused by these pathogens.
Xiaoxuan Feng   +24 more
doaj   +1 more source

Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro

open access: yesAntioxidants, 2020
Non-alcoholic fatty liver disease (NAFLD) causes liver dysfunction and is associated with obesity and type 2 diabetes. Chronic inflammation is associated not only with the development of NAFLD, but also with hepatic diseases, including steatohepatitis ...
Hyun Hwangbo   +10 more
doaj   +1 more source

Auranofin, a Gold(I)-Containing Antirheumatic Compound, Activates Keap1/Nrf2 Signaling via Rac1/iNOS Signal and Mitogen-Activated Protein Kinase Activation

open access: yesJournal of Pharmacological Sciences, 2010
Auranofin (2,3,4,6-tetra-O-acetyl-1-thio-β-d-glucopyranosato-S-[triethylphosphine] gold) is a gold(I)-containing antirheumatic drug that possesses anti-inflammatory properties.
Nam-Hoon Kim   +3 more
doaj   +1 more source

In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection

open access: yesScientific Reports, 2021
Clostridioides difficile infections (CDIs) are an urgent public health threat worldwide and are a leading cause of morbidity and mortality in healthcare settings. The increasing incidence and severity of infections combined with the scarcity of effective
Nader S. Abutaleb, Mohamed N. Seleem
doaj   +1 more source

Home - About - Disclaimer - Privacy